Foon K A, Neubauer R H, Wikstrand C J, Schroff R W, Rabin H, Seeger R C
J Immunogenet. 1984 Jun-Aug;11(3-4):233-43. doi: 10.1111/j.1744-313x.1984.tb01059.x.
A monoclonal antibody designated 'antibody 390' (Ab 390) with anti-human Thy-1 reactivity was prepared by the hybridoma technique from the splenocytes of BALB/c mice immunized with human fetal brain. This antibody was shown to have anti-human Thy-1 reactivity because (1) it precipitated a molecule with a molecular weight of about 24,000 daltons, (2) it had a pattern of reactivity similar to that of previously described anti-human Thy-1 antibodies and (3) purified human Thy-1 antigen specifically inhibited binding of Ab 390 to a known antigen-positive cell line. It was the intent of this study to investigate the distribution of Thy-1 on normal and malignant haematopoietic cells in humans and non-human primates. We show here that Ab 390 did not react with human peripheral blood leucocytes, bone marrow cells or splenocytes by immunofluorescence but did react with subcapsular and cortical fetal thymocytes by peroxidase-antiperoxidase immunohistology. A section of fetal spleen demonstrated staining of connective tissue and blood vessels and rare reactive lymphocytes. Adult spleen contained Thy-1-positive cells surrounding the white pulp and in the marginal zone, but single-cell suspensions of splenocytes did not react with Ab 390. Ab 390 was tested against a variety of fresh human leukaemia cells and human cell lines and was shown to react with only the acute lymphoblastic leukaemia T cell lines RPMI 8402 and HPB-MLT. Non-human primate studies revealed reactivity with a number of T cell lines from New World primates (cotton-topped and red-bellied marmosets) and peripheral blood granulocytes (owl monkey). Our studies support previous findings that suggest that human Thy-1 may be a marker for early T lymphocytes in man, and its distribution on non-human primate T cell lines suggests the same for certain species of non-human primates. Not consistent with the distribution on human cells was the demonstration of Ab 390 reactivity with owl monkey granulocytes.
利用杂交瘤技术,从用人类胎儿脑免疫的BALB/c小鼠脾细胞中制备了一种具有抗人Thy-1反应性的单克隆抗体,命名为“抗体390”(Ab 390)。该抗体显示具有抗人Thy-1反应性,原因如下:(1)它沉淀出一种分子量约为24,000道尔顿的分子;(2)其反应模式与先前描述的抗人Thy-1抗体相似;(3)纯化的人Thy-1抗原特异性抑制Ab 390与已知抗原阳性细胞系的结合。本研究旨在调查Thy-1在人类和非人灵长类动物正常及恶性造血细胞中的分布。我们在此表明,通过免疫荧光法,Ab 390不与人类外周血白细胞、骨髓细胞或脾细胞发生反应,但通过过氧化物酶-抗过氧化物酶免疫组织化学法,它确实与被膜下和皮质胎儿胸腺细胞发生反应。胎儿脾脏切片显示结缔组织和血管染色以及罕见的反应性淋巴细胞。成年脾脏在白髓周围和边缘区含有Thy-1阳性细胞,但脾细胞单细胞悬液不与Ab 390发生反应。对多种新鲜人类白血病细胞和人类细胞系测试了Ab 390,结果显示它仅与急性淋巴细胞白血病T细胞系RPMI 8402和HPB-MLT发生反应。非人灵长类动物研究揭示,它与来自新大陆灵长类动物(棉顶狨和赤腹狨)的一些T细胞系以及外周血粒细胞(夜猴)发生反应。我们的研究支持先前的发现,即提示人类Thy-1可能是人类早期T淋巴细胞的标志物,并且它在非人灵长类动物T细胞系上的分布表明某些非人灵长类动物物种也如此。与在人类细胞上的分布不一致的是,Ab 390与夜猴粒细胞发生反应。